catechin has been researched along with Brain Vascular Disorders in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (25.00) | 18.2507 |
2000's | 2 (50.00) | 29.6817 |
2010's | 1 (25.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cho, WJ; Han, JY; Jung, YD; Kim, JH; Kim, JK; Lee, SG; Oh, BS | 1 |
Appleton, I; Rahman, RM; Sutherland, BA | 1 |
Atsumi, T; Hara, Y; Harada, K; Iijima, H; Komagata, Y; Komiyama, K; Ohashi, K; Ohashi, T; Shimizu, T; Tateishi, M; Watanabe, H; Yamada, H | 1 |
Akashi, T; Niwa, M; Ozaki, M; Taniyama, K; Uchida, S; Yamashita, K | 1 |
1 review(s) available for catechin and Brain Vascular Disorders
Article | Year |
---|---|
Mechanisms of action of green tea catechins, with a focus on ischemia-induced neurodegeneration.
Topics: Antioxidants; Apoptosis; Brain Ischemia; Camellia sinensis; Cardiovascular Diseases; Catechin; Cerebrovascular Disorders; Flavonoids; Free Radical Scavengers; Ischemia; Lipid Peroxidation; Neurodegenerative Diseases; Neuroprotective Agents; Oxidative Stress; Phenols; Polyphenols; Tea | 2006 |
1 trial(s) available for catechin and Brain Vascular Disorders
Article | Year |
---|---|
A randomized clinical study of tea catechin inhalation effects on methicillin-resistant Staphylococcus aureus in disabled elderly patients.
Topics: Administration, Inhalation; Aged; Aged, 80 and over; Catechin; Cerebrovascular Disorders; Chi-Square Distribution; Colony Count, Microbial; Disabled Persons; Drug Administration Schedule; Female; Frail Elderly; Hospitals, General; Humans; Japan; Male; Methicillin Resistance; Prospective Studies; Single-Blind Method; Sputum; Staphylococcal Infections; Staphylococcus aureus; Tea; Treatment Outcome | 2006 |
2 other study(ies) available for catechin and Brain Vascular Disorders
Article | Year |
---|---|
Neurorestorative effects of epigallocatechin-3-Gallate on cognitive function in a chronic cerebral hypoperfusion rat model.
Topics: Animals; Brain-Derived Neurotrophic Factor; Catechin; Cerebrovascular Disorders; Cognition Disorders; Disease Models, Animal; Drug Administration Routes; Escape Reaction; Hippocampus; Male; Malondialdehyde; Maze Learning; Neuroprotective Agents; Pyramidal Cells; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; Superoxide Dismutase; Vascular Endothelial Growth Factor A | 2016 |
Effects of (-)-epigallocatechin-3-O-gallate (green tea tannin) on the life span of stroke-prone spontaneously hypertensive rats.
Topics: Animals; Antihypertensive Agents; Catechin; Cerebrovascular Disorders; Flavonoids; Hydrolyzable Tannins; Hypertension; Life Expectancy; Rats; Rats, Inbred SHR | 1995 |